Background and Objectives: Three-dimensional (3D) coils offer stable initial framing in intracranial aneurysm embolization, but their utility in pulmonary and visceral vascular lesions has not been well established. The objective of this study was to assess the feasibility, safety, and effectiveness of 3D coils used as the primary framing device in pulmonary and visceral embolization. Materials and Methods: This retrospective study included 13 patients with 14 lesions, comprising seven pulmonary arteriovenous malformations (PAVMs), six splenic artery aneurysms (SAAs), and one hepatic artery pseudoaneurysm (HAP), treated between 2024 and 2025. In all lesions, a 0.018-inch 3D coil was deployed as the initial framing coil, followed by further packing with additional 3D or non-3D coils. Technical success, angiographic success, and clinical outcomes were evaluated. Results: Technical success was achieved in all lesions (14/14, 100%; 95% CI, 78.5–100). Angiographic success was achieved in 13 of 14 lesions (92.9%; 95% CI, 68.5–98.7), and clinical success was achieved in 12 of 13 lesions (92.3%; 95% CI, 66.7–98.6). Post-embolization syndrome (PES) developed in five patients with SAAs and in one patient with HAP; all complications were minor and resolved with conservative management. No coil migration or major complications occurred. Conclusions: When used as the initial framing device, 3D coils were technically feasible and achieved acceptable short-term angiographic and clinical outcomes in this small, heterogeneous series; these preliminary findings require confirmation in comparative studies.
Background: Loculated pleural effusion—characterized by fibrinous septations that compartmentalize the pleural space and impede drainage—is a technically demanding indication for percutaneous catheter drainage (PCD), in which accurate catheter placement directly determines drainage success. Whether fluoroscopic guidance reduces reintervention compared with ultrasound guidance alone in this population is unknown. Methods: We conducted a retrospective cohort study of 190 PCD procedures for loculated pleural effusion at a single tertiary-care center (Samsung Changwon Hospital, Changwon, South Korea; 118 ultrasound-guided [US alone], median age 71 years; 72 combined ultrasound-and-fluoroscopy-guided [US + Fluoroscopy], median age 75 years). Underlying etiologies included parapneumonic effusion, empyema, malignant effusion, and other causes. The primary outcome was any reintervention. Between-group comparisons used the Mann–Whitney U and Fisher’s exact tests; adjusted analyses included multivariable logistic regression, 1:1 propensity score matching (PSM), and Cox proportional hazards modeling. Results: Reintervention occurred in 35.6% of US alone versus 18.1% of US + Fluoroscopy procedures (relative risk 0.51, 95% CI 0.29–0.88; p = 0.013). After adjustment, US + Fluoroscopy was associated with lower odds of reintervention (adjusted OR 0.42, 95% CI 0.17–0.95; p = 0.043). PSM (60 matched pairs) confirmed this finding (35.0% vs. 16.7%; McNemar’s p = 0.046). The Cox model showed a directionally consistent association (adjusted HR 0.50, 95% CI 0.25–1.02; p = 0.056; log-rank p = 0.012). Conclusions: Combined ultrasound-and-fluoroscopy guidance was associated with a significantly lower reintervention rate than ultrasound guidance alone, with consistent direction of effect across unadjusted and adjusted analyses. These findings support fluoroscopy as an adjunct modality for this technically demanding indication.